Literature DB >> 17215333

Characterization of Anaplasma phagocytophilum major surface protein 5 and the extent of its cross-reactivity with A. marginale.

N I Strik1, A R Alleman, A F Barbet, H L Sorenson, H L Wamsley, F P Gaschen, N Luckschander, S Wong, F Chu, J E Foley, A Bjoersdorff, S Stuen, D P Knowles.   

Abstract

Major surface protein 5 (Msp5) of Anaplasma marginale is highly conserved in the genus Anaplasma and the antigen used in a commercially available competitive enzyme-linked immunosorbent assay (cELISA) for serologic identification of cattle with anaplasmosis. This study analyzes the degrees of conservation of Msp5 among various isolates of Anaplasma phagocytophilum and the extent of serologic cross-reactivity between recombinant Msp5 (rMsp5) of Anaplasma marginale and A. phagocytophilum. The msp5 genes from various isolates of A. phagocytophilum were sequenced and compared. rMsp5 proteins of A. phagocytophilum and A. marginale were used separately in an indirect ELISA to detect cross-reactivity in serum samples from humans and dogs infected with A. phagocytophilum and cattle infected with A. marginale. Serum samples were also tested with a commercially available competitive ELISA that uses monoclonal antibody ANAF16C1. There were 100% sequence identities in the msp5 genes among all of the A. phagocytophilum isolates from the United States and a horse isolate from Sweden. Sheep isolates from Norway and dog isolates from Sweden were 99% identical to one another but differed in 17 base pairs from the United States isolates and the horse isolate. Serologic cross-reactivity was identified when serum samples from cattle infected with A. marginale were reacted with rMsp5 of A. phagocytophilum and when serum samples from humans and dogs infected with A. phagocytophilum were reacted with rMsp5 of A. marginale in an indirect-ELISA format. Serum samples from dogs or humans infected with A. phagocytophilum did not cross-react with rMsp5 of A. marginale when tested with the commercially available cELISA. These results suggest that rMsp5 of A. phagocytophilum is highly conserved among United States and European isolates and that serologic distinction between A. phagocytophilum and A. marginale infections cannot be accomplished if rMsp5 from either organism is used in an indirect ELISA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215333      PMCID: PMC1828860          DOI: 10.1128/CVI.00320-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  42 in total

1.  Mini-prep in ten minutes.

Authors:  C Zhou; Y Yang; A Y Jong
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

2.  Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

Authors:  S M Read; D H Northcote
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

3.  Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs.

Authors:  B Greig; K M Asanovich; P J Armstrong; J S Dumler
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Evaluation of Anaplasma marginale major surface protein 3 (MSP3) as a diagnostic test antigen.

Authors:  A R Alleman; A F Barbet
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Antibody against an Anaplasma marginale MSP5 epitope common to tick and erythrocyte stages identifies persistently infected cattle.

Authors:  D Knowles; S Torioni de Echaide; G Palmer; T McGuire; D Stiller; T McElwain
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Molecular and serologic evidence of Anaplasma phagocytophilum infection in cats in North America.

Authors:  Michael R Lappin; Edward B Breitschwerdt; Wayne A Jensen; Bridget Dunnigan; Ji-Yeun Rha; C Rogers Williams; Melissa Brewer; Majilinde Fall
Journal:  J Am Vet Med Assoc       Date:  2004-09-15       Impact factor: 1.936

7.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Method for enhancing solubility of the expressed recombinant proteins in Escherichia coli.

Authors:  Sudip Ghosh; Sheeba Rasheedi; Sheikh Showkat Rahim; Sharmistha Banerjee; Rakesh Kumar Choudhary; Prachee Chakhaiyar; Nasreen Z Ehtesham; Sangita Mukhopadhyay; Seyed E Hasnain
Journal:  Biotechniques       Date:  2004-09       Impact factor: 1.993

9.  Molecular cloning of a gene encoding the immunogenic 21 kDa protein of Cowdria ruminantium.

Authors:  S M Mahan; T C McGuire; S M Semu; M V Bowie; F Jongejan; F R Rurangirwa; A F Barbet
Journal:  Microbiology       Date:  1994-08       Impact factor: 2.777

10.  The Anaplasma marginale msp5 gene encodes a 19-kilodalton protein conserved in all recognized Anaplasma species.

Authors:  E S Visser; T C McGuire; G H Palmer; W C Davis; V Shkap; E Pipano; D P Knowles
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more
  13 in total

1.  Molecular characterization of South Indian field isolates of bovine Babesia spp. and Anaplasma spp.

Authors:  Rangapura Kariyappa Pradeep; Murikoli Nimisha; Meethalae Koombayil Sruthi; Pakideery Vidya; Birur Mallappa Amrutha; Prashant Somalingappa Kurbet; Karapparambu Gopalan Ajith Kumar; Anju Varghese; Chundayil Kalarikkal Deepa; Chemmangattuvalappil Narendranath Dinesh; Leena Chandrasekhar; Sanis Juliet; Puthenparambil Ramakrishnan Pradeepkumar; Chintu Ravishankar; Srikant Ghosh; Reghu Ravindran
Journal:  Parasitol Res       Date:  2018-12-17       Impact factor: 2.289

2.  The efficacy of three chlortetracycline regimens in the treatment of persistent Anaplasma marginale infection.

Authors:  James B Reinbold; Johann F Coetzee; Larry C Hollis; Jason S Nickell; Casey Riegel; K C Olson; Roman R Ganta
Journal:  Vet Microbiol       Date:  2010-03-03       Impact factor: 3.293

3.  Comparison of iatrogenic transmission of Anaplasma marginale in Holstein steers via needle and needle-free injection techniques.

Authors:  James B Reinbold; Johann F Coetzee; Larry C Hollis; Jason S Nickell; Casey M Riegel; Julia A Christopher; Roman R Ganta
Journal:  Am J Vet Res       Date:  2010-10       Impact factor: 1.156

4.  Detection of Anaplasma marginale and A. phagocytophilum in bovine peripheral blood samples by duplex real-time reverse transcriptase PCR assay.

Authors:  James B Reinbold; Johann F Coetzee; Kamesh R Sirigireddy; Roman R Ganta
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

5.  Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics.

Authors:  Yan Ge; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

6.  Detection of Anaplasma marginale in Hyalomma asiaticum ticks by PCR assay.

Authors:  Limei Zhang; Yong Wang; Dongjie Cai; Gaoming He; Ziqiang Cheng; Jianzhu Liu; Kai Meng; Dubao Yang; Shujing Wang
Journal:  Parasitol Res       Date:  2013-05-02       Impact factor: 2.289

Review 7.  Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.

Authors:  Farhan Ahmad Atif
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

8.  Anaplasma marginale and A. phagocytophilum in cattle in Tunisia.

Authors:  Youmna M'ghirbi; Marwa Bèji; Beatriz Oporto; Fatma Khrouf; Ana Hurtado; Ali Bouattour
Journal:  Parasit Vectors       Date:  2016-10-20       Impact factor: 3.876

9.  Characterization of recombinant MSP5 Anaplasma marginale Havana isolate.

Authors:  B Corona; H Machado; M Rodríguez; S Martínez
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476

Review 10.  Important hemoprotozoan diseases of livestock: Challenges in current diagnostics and therapeutics: An update.

Authors:  Biswa Ranjan Maharana; Anup Kumar Tewari; Buddhi Chandrasekaran Saravanan; Naduvanahalli Rajanna Sudhakar
Journal:  Vet World       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.